home.social

#glp1 — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #glp1, aggregated by home.social.

  1. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  2. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  3. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  4. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  5. AI scans 400,000 Reddit posts and finds hidden Ozempic side effects. Via @sciencedaily_official #AI #ArtificialIntelligence 💻 🧠 #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    AI scans 400,000 Reddit posts ...

  6. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  7. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  8. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  9. europesays.com/dk/90414/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #A/S #Approval #as #by #CHMP #Class #efficacious #EU #First #for #GLP1 #in #Its #most #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Recommended #representing #semaglutide #the #Treatment #Wegovy

  10. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  11. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  12. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  13. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  14. 💉Taking a GLP-1 RA diabetes/weight loss drug such as Ozempic may slow the growth of some obesity-related cancers

    ✨Follow the link in our bio for more information on this story✨
    scimex.org/newsfeed/ozempic-an

    #science #sciencenews #research #stem #facts #knowledge #sciencefacts #GLP1 #Ozempic #cancer #weightloss

  15. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  16. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  17. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  18. Mounjaro vs Ozempic: head-to-head trial data suggests meaningful differences in weight loss outcomes between the two GLP-1 drugs. The clinical picture is worth reading carefully.

    isitcap.com/r/mounjaro-more-ef

    #GLP1 #Mounjaro #Ozempic #WeightLoss #Medicine #FactCheck

  19. 減肥針恐令肌肉流失一成 停藥後體重反彈快四倍 醫生警告隨時令身體老十歲
    減肥針 GLP-1 藥物近年風靡全球,在美國吸引逾 13,000,000 人使用,甚至帶動大尺碼服飾銷量下跌。 […]
    #健康 #城中熱話 #扮靚科技 #GLP-1副作用
    unwire.hk/2026/05/19/glp1-weig

  20. 減肥針恐令肌肉流失一成 停藥後體重反彈快四倍 醫生警告隨時令身體老十歲
    減肥針 GLP-1 藥物近年風靡全球,在美國吸引逾 13,000,000 人使用,甚至帶動大尺碼服飾銷量下跌。 […]
    #健康 #城中熱話 #扮靚科技 #GLP-1副作用
    unwire.hk/2026/05/19/glp1-weig

  21. 減肥針恐令肌肉流失一成 停藥後體重反彈快四倍 醫生警告隨時令身體老十歲
    減肥針 GLP-1 藥物近年風靡全球,在美國吸引逾 13,000,000 人使用,甚至帶動大尺碼服飾銷量下跌。 […]
    #健康 #城中熱話 #扮靚科技 #GLP-1副作用
    unwire.hk/2026/05/19/glp1-weig

  22. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  23. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  24. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  25. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  26. Niente più iniezioni settimanali, penne in frigo ed effetti collaterali da accumulo: in Olanda è appena partito il primo trial al mondo di una terapia genica GLP-1.

    Una sola infusione direttamente nel pancreas, guidata da ecografia endoscopica, e il pancreas stesso impara a produrre GLP-1 ogni volta che mangi. 9 pazienti per cominciare (con molta cautela), 5 anni di follow-up, primi dati attesi entro fine 2026.

    futuroprossimo.it/2026/05/una-

    #futuroprossimo #GLP1 #terapiagenica #ozempic #salute

  27. The GLP-1 supply chain has four independent bottleneck layers — not one.

    Most coverage focuses on the CDMOs. But three other layers are binding simultaneously:

    1. Peptide synthesis capacity ($5B+ committed, 3-5yr GMP qualification)
    2. Glass containment & elastomer components (West Pharma, Stevanato)
    3. Autoinjector device assembly (BD, $107B market)
    4. Oligonucleotide CDMO (Bachem + Lilly collaboration)

    Full analysis: durability-curve.pages.dev/gho

    #GLP1 #SupplyChain #Biotech #Pharma

  28. Using Weight Loss Drugs May Come With a Downside We Don't Talk About. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    Using Weight Loss Drugs May Co...

  29. Using Weight Loss Drugs May Come With a Downside We Don't Talk About. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    Using Weight Loss Drugs May Co...

  30. Using Weight Loss Drugs May Come With a Downside We Don't Talk About. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    Using Weight Loss Drugs May Co...

  31. Using Weight Loss Drugs May Come With a Downside We Don't Talk About. Via @sciencealert #Health ❤️‍🩹 🧑‍⚕️ #Fitness 🏃🏅🏆 #Ozempic #GLP1

    Using Weight Loss Drugs May Co...

  32. CW: Regarding Weight Loss Drugs

    So, I switched to an oral Wegovy tablet from a compound GLP-1 injectable a few weeks ago, and it's interesting.

    The injectable made me get full faster. With Wegovy, I don't seem to get full faster, but I stay full for much longer, so if I eat a big lunch, I'm not hungry for dinner and end up snacking on a banana, peanuts or chips instead.

    Even if I never lose another pound, not feeling hungry all the time is absolutely wonderful.

  33. CW: Regarding Weight Loss Drugs

    So, I switched to an oral Wegovy tablet from a compound GLP-1 injectable a few weeks ago, and it's interesting.

    The injectable made me get full faster. With Wegovy, I don't seem to get full faster, but I stay full for much longer, so if I eat a big lunch, I'm not hungry for dinner and end up snacking on a banana, peanuts or chips instead.

    Even if I never lose another pound, not feeling hungry all the time is absolutely wonderful.

    #WeightLoss #Wegovy #GLP1 #Food